Search - tctmd.com

Displaying 161 - 180 of 193

Sort: Relevancy | Date

Presentation

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

Presenter: Thomas T. Tsai

October 02, 2015

Presentation Aortovascular 2015

The Medical Treatment of the Patient with PAD in the 21st Century

Presenter: Michael R. Jaff

September 18, 2015

Presentation Aortovascular 2015

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Presenter: Danielle R. Bajakian

September 18, 2015

Presentation

Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease

Presenter: S.K. Padala

September 08, 2015

Presentation CCVVC 2015

Economics of Drug-Coated Technology in PAD

Presenter: Mark W. Burket

June 17, 2015

Presentation Fellows 2015

Workup and Treatment of Lower-Extremity PAD: When to Treat and the Tools You Need

Presenter: William A. Gray, Sahil A. Parikh

May 17, 2015

Presentation

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

Presenter: E.J. Armstrong

April 22, 2015

Presentation

Supervised Exercise, Stent Revascularization, or Medical Therapy for Claudication Due to Aortoiliac PAD

Presenter: Timothy P. Murphy

March 09, 2015

Presentation

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Presenter: G. Tepe

December 15, 2014

Presentation TCT 2014

Side Cell Population and Valve Function

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Muralidhar Padala

September 15, 2014

Presentation TCT 2014

Featured Presentation: Vorapaxar Safety and Efficacy Results in the FDA-Approved, Stroke-Free MI and PAD Populations

Presenter: Ori Ben-Yehuda, Matthew T. Roe, David J. Moliterno, Marc Bonaca

September 15, 2014

Presentation Fellows 2014

Workup and Treatment of Lower Extremity PAD

Presenter: Sahil Parikh

April 14, 2014

Presentation CIT 2014

Case Study of China-Based Innovation:Pulmonary Arterial Denervation(PADN)

Presenter: Shaoliang Chen

March 20, 2014

Presentation

Is There a True Role for Endovascular Intervention for Below-Knee PAD?

Presenter: William A. Gray

December 01, 2013

Presentation TCT 2013

How to Identify Elevated Genetic Risk for Failed AF Ablation (4q25)

Presenter: Paddy Barrett

October 31, 2013

Presentation TCT 2013

Optimized Medical Therapy for the PAD Patient, With or Without Intervention

Presenter: Michael Jaff

October 30, 2013

Presentation TCT 2013

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Presenter: Shao-?Liang Chen

October 29, 2013

Presentation TCT 2013

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Presenter: Shao Liang Chen

October 28, 2013

Presentation TCT 2013

Is There Utility in Close Duplex Follow-up After PAD Intervention?

Presenter: Khusrow Niazi

October 27, 2013

Presentation TCT 2013

Current Status of Lipid Lowering Therapy in CAD, PAD, and CKD

Presenter: Rita Redberg

October 27, 2013

Advertisement

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

The Medical Treatment of the Patient with PAD in the 21st Century

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease

Economics of Drug-Coated Technology in PAD

Workup and Treatment of Lower-Extremity PAD: When to Treat and the Tools You Need

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

Supervised Exercise, Stent Revascularization, or Medical Therapy for Claudication Due to Aortoiliac PAD

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Side Cell Population and Valve Function

Featured Presentation: Vorapaxar Safety and Efficacy Results in the FDA-Approved, Stroke-Free MI and PAD Populations

Workup and Treatment of Lower Extremity PAD

Case Study of China-Based Innovation:Pulmonary Arterial Denervation(PADN)

Is There a True Role for Endovascular Intervention for Below-Knee PAD?

How to Identify Elevated Genetic Risk for Failed AF Ablation (4q25)

Optimized Medical Therapy for the PAD Patient, With or Without Intervention

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Is There Utility in Close Duplex Follow-up After PAD Intervention?

Current Status of Lipid Lowering Therapy in CAD, PAD, and CKD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content